Clinical Trial Update: A Randomized Trial of GM-CSF in Patients With ALI/ARDS [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial of GM-CSF in adults with acute lung injury or acute respiratory distress syndrome has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: University of Michigan | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED | Results posted: 2015-04-27